April 1, 2015: ACTTION Participates in FDA Workshop on Clinical Outcomes Assessment
Robert Dworkin, PhD, and Dennis Turk, PhD, ACTTION Director and Associate Director, were panelists at an FDA Public Workshop on "Clinical Outcomes Assessment Development and Implementation: Opportunities and Challenges." The workshop provided an opportunity for multiple stakeholders to discuss the FDA Clinical Outcomes Initiative, which includes the development of a compendium of clinical outcome assessments and other efforts to advance scientific standards and policy development.